Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2019-10-28 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2019年第一次临时股东大会会议议案
AGM Information Classification · 95% confidence The document is titled '2019年第一次临时股东大会' which translates to '2019 First Extraordinary General Meeting'. It contains detailed agenda items, voting procedures, shareholder participation instructions, and a specific proposal regarding the transfer of a wholly-owned subsidiary's equity. The content is focused on the meeting materials and agenda for the shareholders' meeting rather than the results of voting or a summary of the meeting outcomes. The document length is 4084 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no indication that this is a voting results announcement or a proxy solicitation. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting.
2019-10-28 Chinese
2019年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 Third Quarter Report" of 启迪古汉集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as balance sheets, income statements, cash flow statements, and explanations of financial metrics and changes during the quarter. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is not merely an announcement or a certification. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and analysis. 9M 2019
2019-10-28 Chinese
关于全资子公司拟对外投资建设古汉医药科技园项目并签订项目框架协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company about its wholly-owned subsidiary's planned external investment in a pharmaceutical technology park project. It details the investment amount, project scope, approval status, and risks. It includes information about a board meeting resolution approving the investment. The document is relatively short (2210 characters) and does not contain financial statements or detailed financial performance data. It is an announcement of a corporate investment decision rather than a financial report or regulatory filing. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including significant investment projects.
2019-10-28 Chinese
第八届监事会临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the company's supervisory board regarding the approval of the company's 2019 third quarter report. It states that the supervisory board has reviewed and approved the Q3 report, confirming its compliance and accuracy. The document itself does not contain the full quarterly report or detailed financial data, but rather the announcement of the approval of that report. The document length is short (555 characters), and it serves as a formal announcement of the supervisory board's resolution rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a formal announcement related to regulatory compliance and report approval, not the full Interim/Quarterly Report (IR).
2019-10-28 Chinese
2019年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 Third Quarter Report" of 启迪古汉集团股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net profit, revenue, cash flow, and other financial indicators for the third quarter of 2019. It also includes sections on important matters, shareholder information, and financial performance analysis. The length of the document (8362 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2019
2019-10-28 Chinese
关于召开2019年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2019 first extraordinary general meeting (临时股东大会) of the company 启迪古汉集团股份有限公司. It details the meeting date, voting procedures (including online voting), agenda items (notably the proposal to transfer 100% equity of a subsidiary), registration methods, and other logistical information. There is no financial data, earnings information, or management discussion. The document is primarily an announcement informing shareholders about the meeting and how to participate, rather than the meeting minutes, voting results, or a report. The document length is 3732 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2019-10-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.